Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2004 Oct;59(10):862–869. doi: 10.1136/thx.2003.017244

Airway inflammation in children with difficult asthma: relationships with airflow limitation and persistent symptoms

D Payne 1, Y Qiu 1, J Zhu 1, L Peachey 1, M Scallan 1, A Bush 1, P Jeffery 1
PMCID: PMC1746838  PMID: 15454652

Abstract

Background: The effective management and development of new treatments for children with difficult asthma requires investigation of the underlying airway pathology and its relationships with persistent symptoms and airflow limitation.

Methods: The density of immunologically distinct inflammatory cells and cells expressing interleukin (IL)-4, IL-5, and RANTES was determined in paraffin-embedded endobronchial biopsy specimens from 27 children with difficult asthma (6–16 years) following treatment with systemic corticosteroids. Eleven non-asthmatic children (7–16 years) acted as controls. Reticular basement membrane (RBM) thickness was also recorded and forced expiratory volume in 1 second (FEV1) and exhaled nitric oxide (FENO) measured, the latter in asthmatic children only.

Results: RBM thickness was greater in the asthmatic than the control group (median (range) 7.4 (3.1–11.1) v 5.1 (3.5–7.5) µm, p = 0.02). No other significant tissue difference was seen, nor was there a difference between asthmatic subjects with daily symptoms after systemic corticosteroids and those who became asymptomatic. CD4+ T lymphocyte density was higher in asthmatic subjects with persistent airflow limitation (post-bronchodilator FEV1<80% predicted) than in those without (9.1 (5.5–13.6) v 3.5 (0.6–34.9)%, p = 0.027). Analysing all asthmatic subjects together, there were negative correlations between CD4+ T lymphocytes and both pre-bronchodilator FEV1 (r = –0.57 (95% CI –0.79 to –0.23), p = 0.002) and post-bronchodilator FEV1 (r = –0.61 (95% CI –0.81 to –0.29), p<0.001). There were no significant correlations between FENO and inflammatory cells of any type.

Conclusion: In children with difficult asthma treated with systemic corticosteroids, persistent airflow limitation is associated with a greater density of CD4+ T lymphocytes in endobronchial biopsy specimens.

Full Text

The Full Text of this article is available as a PDF (178.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baraldi E., de Jongste J. C., European Respiratory Society/American Thoracic Society (ERS/ATS) Task Force Measurement of exhaled nitric oxide in children, 2001. Eur Respir J. 2002 Jul;20(1):223–237. doi: 10.1183/09031936.02.00293102. [DOI] [PubMed] [Google Scholar]
  2. Barbato Angelo, Turato Graziella, Baraldo Simonetta, Bazzan Erica, Calabrese Fiorella, Tura Maria, Zuin Renzo, Beghe Bianca, Maestrelli Piero, Fabbri Leonardo M. Airway inflammation in childhood asthma. Am J Respir Crit Care Med. 2003 Jul 31;168(7):798–803. doi: 10.1164/rccm.200305-650OC. [DOI] [PubMed] [Google Scholar]
  3. Bush A., de Jongste J. C., Carlsen K-H. Ultrastructural examination of bronchial specimens from children with moderate asthma. Thorax. 2003 Feb;58(2):187–188. doi: 10.1136/thorax.58.2.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chan M. T., Leung D. Y., Szefler S. J., Spahn J. D. Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma. J Allergy Clin Immunol. 1998 May;101(5):594–601. doi: 10.1016/S0091-6749(98)70165-4. [DOI] [PubMed] [Google Scholar]
  5. Corrigan C. J., Brown P. H., Barnes N. C., Szefler S. J., Tsai J. J., Frew A. J., Kay A. B. Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis. 1991 Nov;144(5):1016–1025. doi: 10.1164/ajrccm/144.5.1016. [DOI] [PubMed] [Google Scholar]
  6. Gamble Elizabeth, Grootendorst Diana C., Brightling Christopher E., Troy Susannah, Qiu Yusheng, Zhu Jie, Parker Debbie, Matin Dean, Majumdar Swati, Vignola Antonio M. Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003 Jun 19;168(8):976–982. doi: 10.1164/rccm.200212-1490OC. [DOI] [PubMed] [Google Scholar]
  7. Jeffery Peter, Holgate Stephen, Wenzel Sally, Endobronchial Biopsy Workshop Methods for the assessment of endobronchial biopsies in clinical research: application to studies of pathogenesis and the effects of treatment. Am J Respir Crit Care Med. 2003 Sep 15;168(6 Pt 2):S1–17. doi: 10.1164/rccm.200202-150WS. [DOI] [PubMed] [Google Scholar]
  8. Jenkins Henry A., Cool Carlyne, Szefler Stanley J., Covar Ronina, Brugman Susan, Gelfand Erwin W., Spahn Joseph D. Histopathology of severe childhood asthma: a case series. Chest. 2003 Jul;124(1):32–41. doi: 10.1378/chest.124.1.32. [DOI] [PubMed] [Google Scholar]
  9. Krawiec M. E., Westcott J. Y., Chu H. W., Balzar S., Trudeau J. B., Schwartz L. B., Wenzel S. E. Persistent wheezing in very young children is associated with lower respiratory inflammation. Am J Respir Crit Care Med. 2001 May;163(6):1338–1343. doi: 10.1164/ajrccm.163.6.2005116. [DOI] [PubMed] [Google Scholar]
  10. Leung D. Y., Martin R. J., Szefler S. J., Sher E. R., Ying S., Kay A. B., Hamid Q. Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J Exp Med. 1995 Jan 1;181(1):33–40. doi: 10.1084/jem.181.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mahut Bruno, Delclaux Christophe, Tillie-Leblond Isabelle, Gosset Philippe, Delacourt Christophe, Zerah-Lancner Françoise, Harf Alain, de Blic Jacques. Both inflammation and remodeling influence nitric oxide output in children with refractory asthma. J Allergy Clin Immunol. 2004 Feb;113(2):252–256. doi: 10.1016/j.jaci.2003.10.038. [DOI] [PubMed] [Google Scholar]
  12. Payne D. N., Adcock I. M., Wilson N. M., Oates T., Scallan M., Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med. 2001 Oct 15;164(8 Pt 1):1376–1381. doi: 10.1164/ajrccm.164.8.2101145. [DOI] [PubMed] [Google Scholar]
  13. Payne D. N., Balfour-Lynn I. M. Children with difficult asthma: a practical approach. J Asthma. 2001 May;38(3):189–203. doi: 10.1081/jas-100000106. [DOI] [PubMed] [Google Scholar]
  14. Payne D. N., Wilson N. M., James A., Hablas H., Agrafioti C., Bush A. Evidence for different subgroups of difficult asthma in children. Thorax. 2001 May;56(5):345–350. doi: 10.1136/thorax.56.5.345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Payne Donald N. R., Rogers Andrew V., Adelroth Ellinor, Bandi Venkata, Guntupalli Kalpalatha K., Bush Andrew, Jeffery Peter K. Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med. 2003 Jan 1;167(1):78–82. doi: 10.1164/rccm.200205-414OC. [DOI] [PubMed] [Google Scholar]
  16. Piacentini G. L., Bodini A., Costella S., Vicentini L., Mazzi P., Sperandio S., Boner A. L. Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children. Eur Respir J. 1999 Jun;13(6):1386–1390. doi: 10.1183/09031936.99.13613919. [DOI] [PubMed] [Google Scholar]
  17. Ram Felix S. F., Wedzicha Jadwiga A., Wright John, Greenstone Michael. Hospital at home for patients with acute exacerbations of chronic obstructive pulmonary disease: systematic review of evidence. BMJ. 2004 Jul 8;329(7461):315–315. doi: 10.1136/bmj.38159.650347.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rasmussen Finn, Taylor D. Robin, Flannery Erin M., Cowan Jan O., Greene Justina M., Herbison G. Peter, Sears Malcolm R. Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: a longitudinal population study from childhood to adulthood. Am J Respir Crit Care Med. 2002 Jun 1;165(11):1480–1488. doi: 10.1164/rccm.2108009. [DOI] [PubMed] [Google Scholar]
  19. Richmond I., Booth H., Ward C., Walters E. H. Intrasubject variability in airway inflammation in biopsies in mild to moderate stable asthma. Am J Respir Crit Care Med. 1996 Mar;153(3):899–903. doi: 10.1164/ajrccm.153.3.8630570. [DOI] [PubMed] [Google Scholar]
  20. Syed F., Bingham B., Johnson M., Markham A. F., Morrison J. F. The CD4+ T lymphocyte is a site of steroid resistance in asthma. QJM. 1998 Aug;91(8):567–572. doi: 10.1093/qjmed/91.8.567. [DOI] [PubMed] [Google Scholar]
  21. Warke T. J., Fitch P. S., Brown V., Taylor R., Lyons J. D. M., Ennis M., Shields M. D. Exhaled nitric oxide correlates with airway eosinophils in childhood asthma. Thorax. 2002 May;57(5):383–387. doi: 10.1136/thorax.57.5.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Zhu J., Qiu Y. S., Majumdar S., Gamble E., Matin D., Turato G., Fabbri L. M., Barnes N., Saetta M., Jeffery P. K. Exacerbations of Bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants. Am J Respir Crit Care Med. 2001 Jul 1;164(1):109–116. doi: 10.1164/ajrccm.164.1.2007050. [DOI] [PubMed] [Google Scholar]
  23. de Blic Jacques, Tillie-Leblond Isabelle, Tonnel André Bernard, Jaubert Francis, Scheinmann Pierre, Gosset Philippe. Difficult asthma in children: an analysis of airway inflammation. J Allergy Clin Immunol. 2004 Jan;113(1):94–100. doi: 10.1016/j.jaci.2003.10.045. [DOI] [PubMed] [Google Scholar]
  24. van den Toorn L. M., Overbeek S. E., de Jongste J. C., Leman K., Hoogsteden H. C., Prins J. B. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med. 2001 Dec 1;164(11):2107–2113. doi: 10.1164/ajrccm.164.11.2006165. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES